After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Merck & Co Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. The current market capitalization of Merck & Co Inc is $318.93B. A total of 6.34 million shares were traded on the day, compared to an average of 8.36M shares.
In the most recent transaction, Merck & Co., Inc. bought 21,397,205 shares of MRK for 23.00 per share on Mar 11 ’24. After the transaction, the 10% Owner now owns 1,000 company shares. In a previous transaction on Feb 14 ’24, Davis Robert M sold 85,021 shares at 125.40 per share. MRK shares that Chairman, CEO & President owns now total 348,327.
Among the insiders who sold shares, Litchfield Caroline disposed of 38,291 shares on Feb 14 ’24 at a per-share price of $125.50. This resulted in the EVP & CFO holding 50,908 shares of MRK after the transaction. In another insider transaction, Davis Robert M sold 150,000 shares at $125.85 per share on Feb 13 ’24. Company shares held by the Chairman, CEO & President now total 348,327.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Merck & Co Inc pays an annual dividend of $3.04, resulting in a dividend yield of 2.41%, and it has a price to earnings (P/E) ratio of 140.18. MRK’s most recent ex-dividend date was 9/16/2024 when it declared a $0.77 quarterly dividend that was paid in cash on 10/7/2024. Previously, the company paid the dividend on 7/8/2024 with an ex-dividend date of 6/17/2024. The MRK stock dividend was $0.77 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, MRK has a high of $134.63 and a low of $99.14.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MRK’s latest balance sheet shows that the firm has $8.10B in Cash & Short Term Investments as of fiscal 2021. There were $33.10B in debt and $23.87B in liabilities at the time. Its Book Value Per Share was $15.94, while its Total Shareholder’s Equity was $38.26B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRK is Buy with a score of 4.83.
